Literature DB >> 31400756

Potential Antigenic Mismatch of the H3N2 Component of the 2019 Southern Hemisphere Influenza Vaccine.

Sigrid Gouma1, Madison Weirick1, Scott E Hensley1.   

Abstract

Here, we find that the egg-adapted H3N2 component of the 2019 Southern Hemisphere influenza vaccine elicits an antibody response in ferrets that is highly focused on antigenic site A of hemagglutinin. This is potentially problematic as most H3N2 viruses currently circulating in the Southern Hemisphere possess antigenic site A substitutions.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  H3N2; hemagglutinin; influenza vaccine; influenza virus

Year:  2020        PMID： 31400756      PMCID： PMC7245157          DOI： 10.1093/cid/ciz723

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  9 in total

Review 1.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

2.  Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.

Authors:  Yang Li; David L Bostick; Colleen B Sullivan; Jaclyn L Myers; Sara B Griesemer; Kirsten Stgeorge; Joshua B Plotkin; Scott E Hensley
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

Review 3.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

4.  Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season.

Authors:  Benjamin S Chambers; Kaela Parkhouse; Ted M Ross; Kevin Alby; Scott E Hensley
Journal:  Cell Rep       Date:  2015-06-25       Impact factor: 9.423

5.  Plasticity of Amino Acid Residue 145 Near the Receptor Binding Site of H3 Swine Influenza A Viruses and Its Impact on Receptor Binding and Antibody Recognition.

Authors:  Jefferson J S Santos; Eugenio J Abente; Adebimpe O Obadan; Andrew J Thompson; Lucas Ferreri; Ginger Geiger; Ana S Gonzalez-Reiche; Nicola S Lewis; David F Burke; Daniela S Rajão; James C Paulson; Amy L Vincent; Daniel R Perez
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

6.  2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

Authors:  Richard K Zimmerman; Mary Patricia Nowalk; Jessie Chung; Michael L Jackson; Lisa A Jackson; Joshua G Petrie; Arnold S Monto; Huong Q McLean; Edward A Belongia; Manjusha Gaglani; Kempapura Murthy; Alicia M Fry; Brendan Flannery
Journal:  Clin Infect Dis       Date:  2016-10-04       Impact factor: 20.999

7.  Nextstrain: real-time tracking of pathogen evolution.

Authors:  James Hadfield; Colin Megill; Sidney M Bell; John Huddleston; Barney Potter; Charlton Callender; Pavel Sagulenko; Trevor Bedford; Richard A Neher
Journal:  Bioinformatics       Date:  2018-12-01       Impact factor: 6.931

8.  Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.

Authors:  Lyubov Popova; Kenneth Smith; Ann H West; Patrick C Wilson; Judith A James; Linda F Thompson; Gillian M Air
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

9.  Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.

Authors:  Seth J Zost; Kaela Parkhouse; Megan E Gumina; Kangchon Kim; Sebastian Diaz Perez; Patrick C Wilson; John J Treanor; Andrea J Sant; Sarah Cobey; Scott E Hensley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205
  9 in total
  3 in total

1.  Differential Antibody Recognition of H3N2 Vaccine and Seasonal Influenza Virus Strains Based on Age, Vaccine Status, and Sex in the 2017-2018 Season.

Authors:  Rebecca L Ursin; Hsuan Liu; Harrison R Powell; Jason W Westerbeck; Kathryn Shaw-Saliba; Kristyn E Sylvia; Katherine J Fenstermacher; Tom Mehoke; Peter Thielen; Richard E Rothman; Andrew Pekosz; Sabra L Klein
Journal:  J Infect Dis       Date:  2020-09-14       Impact factor: 5.226

2.  A Single Amino Acid Residue R144 of SNX16 Affects Its Ability to Inhibit the Replication of Influenza A Virus.

Authors:  Wenjun Shi; Li Jiang; Miaomiao Ye; Bo Wang; Yu Chang; Zhibo Shan; Xuyuan Wang; Yuzhen Hu; Hualan Chen; Chengjun Li
Journal:  Viruses       Date:  2022-04-15       Impact factor: 5.818

Review 3.  The role of cell-mediated immunity against influenza and its implications for vaccine evaluation.

Authors:  Yorick Janssens; Jasper Joye; Gwenn Waerlop; Frédéric Clement; Geert Leroux-Roels; Isabel Leroux-Roels
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.